title: Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
authors.forename: Sanjay
authors.initials: S
authors.lastname: Pujari
authors.forename: Atul
authors.initials: A
authors.lastname: Patel
authors.forename: Shashank R
authors.initials: SR
authors.lastname: Joshi
authors.forename: Raman
authors.initials: R
authors.lastname: Gangakhedkar
authors.forename: N
authors.initials: N
authors.lastname: Kumarasamy
authors.forename: S B
authors.initials: SB
authors.lastname: Gupta
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000465:Algorithms; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003906:Developing Countries; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D015658:HIV Infections / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007194:India; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D011247:Pregnancy; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D016312:Treatment Refusal; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors